• bitcoinBitcoin(BTC)$77,952.00-2.54%
  • ethereumEthereum(ETH)$2,227.33-3.74%
  • tetherTether(USDT)$1.000.00%
  • binancecoinBNB(BNB)$705.60-6.24%
  • rippleXRP(XRP)$1.25-2.89%
  • usd-coinUSDC(USDC)$1.000.01%
  • solanaSolana(SOL)$97.19-2.72%
  • tronTRON(TRX)$0.3320370.18%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.03-0.07%
  • HyperliquidHyperliquid(HYPE)$91.6715.98%
  • zcashZcash(ZEC)$1,249.000.36%
  • dogecoinDogecoin(DOGE)$0.075701-2.81%
  • moneroMonero(XMR)$597.520.73%
  • USDSUSDS(USDS)$1.00-0.17%
  • whitebitWhiteBIT Coin(WBT)$74.57-2.80%
  • leo-tokenLEO Token(LEO)$9.42-0.30%
  • chainlinkChainlink(LINK)$11.04-3.51%
  • cardanoCardano(ADA)$0.192149-3.10%
  • stellarStellar(XLM)$0.165690-1.35%
  • nearNEAR Protocol(NEAR)$4.34-0.02%
  • bitcoin-cashBitcoin Cash(BCH)$281.150.67%
  • daiDai(DAI)$1.000.00%
  • RainRain(RAIN)$0.006397-6.45%
  • Ethena USDeEthena USDe(USDE)$1.00-0.12%
  • litecoinLitecoin(LTC)$55.68-2.33%
  • uniswapUniswap(UNI)$6.70-4.56%
  • USD1USD1(USD1)$1.00-0.04%
  • avalanche-2Avalanche(AVAX)$8.47-2.30%
  • CantonCanton(CC)$0.093383-2.84%
  • suiSui(SUI)$0.88-2.90%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.19-1.95%
  • tether-goldTether Gold(XAUT)$3,984.40-0.89%
  • hedera-hashgraphHedera(HBAR)$0.071072-3.53%
  • Global DollarGlobal Dollar(USDG)$1.000.04%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.13%
  • quant-networkQuant(QNT)$195.561.38%
  • shiba-inuShiba Inu(SHIB)$0.000005-3.22%
  • BittensorBittensor(TAO)$234.23-5.53%
  • crypto-com-chainCronos(CRO)$0.051564-1.83%
  • Ripple USDRipple USD(RLUSD)$1.000.02%
  • EthenaEthena(ENA)$0.189187-4.16%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.15%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • okbOKB(OKB)$112.261.10%
  • MemeCoreMemeCore(M)$1.01-4.65%
  • BitwayBitway(BTW)$1.47-18.67%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • pepePepe(PEPE)$0.0000051.14%
  • aaveAave(AAVE)$124.96-4.21%
  • OndoOndo(ONDO)$0.389437-4.22%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

This Paper Explores the Future of Diagnosing and Managing Chronic Painful Temporomandibular Disorders: The Revolutionary Role of AI and Neuroimaging

December 31, 2023
in AI & Technology
Reading Time: 5 mins read
A A
This Paper Explores the Future of Diagnosing and Managing Chronic Painful Temporomandibular Disorders: The Revolutionary Role of AI and Neuroimaging
ShareShareShareShareShare

Chronic painful Temporomandibular Disorders (TMD) present a multifaceted challenge in the medical field, primarily due to their intricate nature and the complexity of effectively diagnosing and treating them. Understanding the underlying mechanisms is crucial as a prevalent condition causing significant personal and economic impacts. The evolution of neuroimaging techniques has significantly advanced our understanding, highlighting the link between brain activity and the subjective experience of pain. Recent years have seen a transformative integration of Artificial Intelligence (AI) into this realm, pushing the boundaries of our knowledge and capabilities in managing these disorders.

TMDs, affecting a substantial segment of the population, lead to a considerable burden on both individuals and healthcare systems. The etiology of these disorders is multifactorial, involving a dynamic interplay of biomechanical, biopsychosocial, and neural factors. This complexity necessitates a nuanced and comprehensive approach to their diagnosis and management, which has been a persistent challenge in the medical community.

Traditional methods have primarily relied on various neuroimaging techniques like MRI and PET scans to understand and diagnose TMD. These methods have been instrumental in revealing the structural and functional changes within the brain’s pain-related networks. However, the effectiveness of these techniques in diagnosing chronic painful TMD has yet to be fully exploited. This gap presents an opportunity for the integration of emerging technologies like AI.

Integrating AI with neuroimaging represents a significant leap forward in TMD research. AI, particularly through machine learning and deep learning, has been applied to analyze patient data more effectively. This integration is crucial for early diagnosis and prediction of chronic pain disorders. When applied to imaging and non-imaging data, AI algorithms have shown a remarkable ability to identify patterns and abnormalities that might otherwise go unnoticed. This application is particularly relevant in understanding the pathophysiology of TMD and enhancing our understanding of the mechanisms behind pain chronicity.

https://www.nature.com/articles/s41368-023-00254-z

Regarding methodology, AI algorithms have been used to analyze neuroimaging data, aiding in identifying brain patterns based on structural and functional changes. This approach has enabled a more nuanced understanding of TMD pathophysiology. AI-based tools can quantify TMD, facilitating a more accurate diagnosis and a better understanding of the disorder’s progression and treatment response.

As highlighted by this survey, the results of integrating AI in TMD research have been promising. AI-enhanced neuroimaging methods have improved diagnostic accuracy, crucial for effective patient management and treatment. These algorithms have demonstrated the potential to increase the sensitivity and specificity of TMD diagnosis, which is a significant advancement given the complexity of the disorder. This approach has been particularly useful in identifying and categorizing lesions in various medical conditions, indicating its applicability in TMD diagnosis and management.

In conclusion, integrating neuroimaging and AI in chronic painful TMD research represents a notable advancement in the medical field. This combination enhances our understanding and diagnostic capability of the disorder and opens new avenues for more effective and personalized treatment strategies. The synergy of these technologies is key to unlocking new dimensions in chronic pain management, offering hope for improved patient outcomes in the face of a challenging medical condition.


Check out the Paper. All credit for this research goes to the researchers of this project. Also, don’t forget to join our 35k+ ML SubReddit, 41k+ Facebook Community, Discord Channel, LinkedIn Group, and Email Newsletter, where we share the latest AI research news, cool AI projects, and more.

If you like our work, you will love our newsletter..


YOU MAY ALSO LIKE

General Motors Agrees To Pay $220 Million To Settle Multi-State Data Privacy Lawsuit

Edge0 Releases Audio8-TTS-Realistic, a 0.6B Voice Cloning TTS Model

Muhammad Athar Ganaie, a consulting intern at MarktechPost, is a proponet of Efficient Deep Learning, with a focus on Sparse Training. Pursuing an M.Sc. in Electrical Engineering, specializing in Software Engineering, he blends advanced technical knowledge with practical applications. His current endeavor is his thesis on “Improving Efficiency in Deep Reinforcement Learning,” showcasing his commitment to enhancing AI’s capabilities. Athar’s work stands at the intersection “Sparse Training in DNN’s” and “Deep Reinforcemnt Learning”.


🎯 Meet AImReply: Your New AI Email Writing Extension…. Try it free now!.

Credit: Source link

ShareTweetSendSharePin

Related Posts

General Motors Agrees To Pay 0 Million To Settle Multi-State Data Privacy Lawsuit
AI & Technology

General Motors Agrees To Pay $220 Million To Settle Multi-State Data Privacy Lawsuit

October 30, 2026
Edge0 Releases Audio8-TTS-Realistic, a 0.6B Voice Cloning TTS Model
AI & Technology

Edge0 Releases Audio8-TTS-Realistic, a 0.6B Voice Cloning TTS Model

October 30, 2026
Microsoft Offers Buyouts to 60,000 Employees
AI & Technology

Microsoft Offers Buyouts to 60,000 Employees

October 30, 2026
Meta Looks to Raise  Billion From Stock Sale to Fund AI Investments
AI & Technology

Meta Looks to Raise $95 Billion From Stock Sale to Fund AI Investments

October 30, 2026
Next Post
Tom Wilkinson, Actor in ‘The Full Monty,’ Dies at 75

Tom Wilkinson, Actor in ‘The Full Monty,’ Dies at 75

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Truist Financial: Combination Of High-Yielding Preferreds And Common Stock Makes Sense

Truist Financial: Combination Of High-Yielding Preferreds And Common Stock Makes Sense

October 24, 2026
The next AI stock to double is ___. The most overrated Mag 7 stock is ___.

The next AI stock to double is ___. The most overrated Mag 7 stock is ___.

October 27, 2026
AI-Made Political Ads Jump Ahead of Midterms

AI-Made Political Ads Jump Ahead of Midterms

October 29, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!